Category: Biopharmaceuticals
Asia Biopharmaceuticals
-
2024 Japan Single-Use Bioprocessing Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 India Single-Use Bioprocessing Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
Biologics Contract Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... The global biologics contract manufacturing market is set for remarkable growth, with worldwide revenue anticipated to increase from USD 16.01 billion in 2024 to an impressive USD 36.3 billion by 2031. Projected to grow at ... Read More
-
Wireless Power Transmission Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 6.0% during 2025-2034. This report on global wireless power transmission market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of ... Read More
-
2024 Asia-Pacific Biologics Contract Manufacturing Forecast (2025-2030 Outlook)-Market Opportunities Report
... industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are published ... Read More
-
2024 China Biologics Contract Manufacturing Forecast (2025-2030 Outlook)-Market Opportunities Report
... industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are published ... Read More
-
2024 Japan Biologics Contract Manufacturing Forecast (2025-2030 Outlook)-Market Opportunities Report
... industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are published ... Read More
-
2024 India Biologics Contract Manufacturing Forecast (2025-2030 Outlook)-Market Opportunities Report
... industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are published ... Read More
-
Asia Pacific Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)
... Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others) The Asia Pacific bioprocessing market was valued at US$ 5,488.87 million in 2023 and is expected ... Read More
-
Asia Pacific Biopharma Excipients Market Size, Share & Trends Analysis Report By Product (Solubilizers & Surfactants/Emulsifiers, Polyols, Carbohydrates, Specialty Biopharma Excipients), By Country, And Segment Forecasts, 2024 - 2030
... & Trends The Asia Pacific biopharma excipient market size is expected to reach USD 1.1 billion in 2030 and is projected to grow at a CAGR of 5.8% from 2024 to 2030. Patent expiry of ... Read More
-
India Generic Drugs Market Assessment, By Application [Neurovascular, Cardiovascular, Dermatology, Oncology, Diabetology, Respiratory, Others], By Type [Biosimilar Generics, Small Molecule Generics], By Brand [Branded Generic, Pure Generic], By Route of Administration [Oral, Injectable, Topical, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, FY2018-FY2032F
... By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, FY2018-FY2032F India generic drugs market is projected to witness a CAGR of 8.29% during the forecast period FY2025-FY2032, growing from USD ... Read More
-
Japan Biosimilars Market, By Product (Monoclonal Antibodies, Recombinant Hormones, Immunomodulators, Anti-inflammatory Agents, Other), By Application (Blood Disorders, Growth Hormonal Deficiency, Chronic and Autoimmune Disorders, Oncology, Other), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Competition Forecast & Opportunities, 2020-2030F
... By Region, Competition Forecast & Opportunities, 2020-2030F Japan Biosimilars Market was valued at USD 502.09 Million in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 10.12% through ... Read More
-
Japan Generic Drugs Market Assessment, By Application [Neurovascular, Cardiovascular, Dermatology, Oncology, Diabetology, Respiratory, Others], By Type [Biosimilar Generics, Small Molecule Generics], By Brand [Branded Generic, Pure Generic], By Route of Administration [Oral, Injectable, Topical, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, FY2018-FY2032F
... By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, FY2018-FY2032F Japan generic drugs market is projected to witness a CAGR of 7.81% during the forecast period FY2024-FY2032, growing from USD ... Read More
-
Vietnam Generic Drugs Market Assessment, By Application [Neurovascular, Cardiovascular, Dermatology, Oncology, Diabetology, Respiratory, Others], By Type [Biosimilar Generics, Small Molecule Generics], By Brand [Branded Generic, Pure Generic], By Route of Administration [Oral, Injectable, Topical, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F
... By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F Vietnam generic drugs market is projected to witness a CAGR of 8.39% during the forecast period 2024-2031, growing from USD ... Read More
-
Gastroenterology Market, By Drug Type (Biologics/Biosimilars, Antacids, Laxatives, Antidiarrheal Agents, Antiemetics, Antiulcer Agents, Others), By Dosage Form (Oral, Parenteral, Others), By Disease Type (Inflammatory Bowel Diseases (IBD), Crohn\'s Disease, Ulcerative Colitis, Irritable Bowel Syndrome (IBS), Gastroesophageal Reflux Disease, Liver Diseases, Colorectal Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... Gastroesophageal Reflux Disease, Liver Diseases, Colorectal Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) Global gastroenterology market growth is ... Read More
-
Japan Human Insulin Market By Product Type (Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin, Biosimilars), By Application (Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus), By Type (Human Insulin, Insulin Analog), By Distribution Channel (Hospitals, Retail Pharmacies, and Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
... Pharmacies, and Others), By Region, Competition, Forecast & Opportunities, 2020-2030F Japan Human Insulin Market was valued at USD 840.23 Million in 2024 and is expected to reach USD 1206.28 Million by 2030 with a CAGR ... Read More
-
Pegfilgrastim Biosimilars Market, By Product (Pegfilgrastim Biosimilars and Pegfilgrastim Reference Product), By Application (Oncology, Chronic Neutropenia, Stem Cell Transplantation, Others), By Route of Administration (Subcutaneous and Intravenous), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Pegfilgrastim is a long-acting form of filgrastim that stimulates the bone marrow to produce more white blood cells. Pegfilgrastim biosimilars are ... Read More
-
Biopharmaceuticals Industry Forecasts - China Focus
... and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the ... Read More
-
Biopharmaceuticals Companies in China
... capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is ... Read More
-
Biopharmaceuticals Markets in China
... high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, ... Read More
-
India Host Cell Protein Testing Market Research Report Information by Product Type (PCR-based assays, ELISA-based assays, mass spectrometry-based assays and others), by End User (Contract Research Organizations, Biopharmaceutical Companies, and Others) – Industry Forecast to 2032
... 2032 It is projected that the India host cell protein testing market will grow at a robust rate of 99.12% over the course of the review year. During the biotherapeutic manufacturing process, the host organism ... Read More
-
Biosimilars Market, By Drug Class (Recombinant Human Growth Hormone, Granulocyte Colony-Stimulating Factor, Insulin, Anticoagulants, Fusion Proteins Erythropoietin, Monoclonal Antibodies, Follitropin, Others), By Therapy Type (Oncology, Immunology, Hematology, Hormone Therapy, Metabolic Disorders, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Global biosimilars market growth is driven by rising healthcare costs worldwide and the expiration of blockbuster ... Read More
-
India Life Science & Analytical Instruments Market Research Report Data by Instrument Type (Sterilizers, Bioreactors, Washers, Isolators, Aseptic Transfer Equipment, and Others), by Application (Clinical and Diagnostics, Research, and Others), and by End User (Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, and Others) Forecast till 2032
... and Biotechnology Companies, Hospitals and Diagnostic Laboratories, and Others) Forecast till 2032 In 2023, the market for analytical instruments and life sciences in India was estimated to be worth USD 0.27 billion. The life science ... Read More
-
Cell Cryopreservation Market, By Product Type (Cryoprotectant Agents and Equipment), By Application (Stem Cells, Oocytes and Embryotic cells, Sperm Cells, Hepatocytes, Others), By End User (Biopharmaceutical & Pharmaceutical Companies, Research Institutes, Biobank, IVF clinics, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Cell cryopreservation involves preserving cells by cooling them to extremely low temperatures, usually -80°C or below using liquid nitrogen. It helps to ... Read More
-
Biologics Markets in China
... high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, ... Read More
Research Assistance
